Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats
- 1 May 2001
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1536 (2-3) , 185-195
- https://doi.org/10.1016/s0925-4439(01)00045-x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Effect of insulin-like growth factor I on in vivo intestinal absorption ofd-galactose in cirrhotic ratsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1999
- Prognostic value of insulinlike growth factor I and its binding protein in patients with alcohol-induced liver diseaseHepatology, 1996
- Urinary growth hormone (U-GH) excretion and serum insulin-like growth factor 1 (IGF-1) in patients with alcoholic cirrhosisJournal of Hepatology, 1993
- Serum growth hormone-binding protein, insulin-like growth factor-I, and growth hormone in patients with liver cirrhosisMetabolism, 1992
- Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosisJournal of Endocrinological Investigation, 1991
- Connective Tissue Biology and Hepatic Fibrosis: Report of A ConferenceHepatology, 1990
- Ito–Cell Gene Expression and Collagen RegulationHepatology, 1990
- Post‐Translational Processing of ProcollagensAnnals of the New York Academy of Sciences, 1985
- SOMATOMEDIN PRODUCTION IN NORMAL ADULTS AND CIRRHOTIC PATIENTSActa Endocrinologica, 1977
- Activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in the liver of rats with hepatic injuryBiochemical Journal, 1974